207 related articles for article (PubMed ID: 22427728)
1. Review of eprodisate for the treatment of renal disease in AA amyloidosis.
Rumjon A; Coats T; Javaid MM
Int J Nephrol Renovasc Dis; 2012; 5():37-43. PubMed ID: 22427728
[TBL] [Abstract][Full Text] [Related]
2. Eprodisate for the treatment of renal disease in AA amyloidosis.
Dember LM; Hawkins PN; Hazenberg BP; Gorevic PD; Merlini G; Butrimiene I; Livneh A; Lesnyak O; Puéchal X; Lachmann HJ; Obici L; Balshaw R; Garceau D; Hauck W; Skinner M;
N Engl J Med; 2007 Jun; 356(23):2349-60. PubMed ID: 17554116
[TBL] [Abstract][Full Text] [Related]
3. Eprodisate in amyloid A amyloidosis: a novel therapeutic approach?
Manenti L; Tansinda P; Vaglio A
Expert Opin Pharmacother; 2008 Aug; 9(12):2175-80. PubMed ID: 18671471
[TBL] [Abstract][Full Text] [Related]
4. [Systemic AA amyloidosis induced by benign neoplasms].
Bestard Matamoros O; Poveda Monje R; Ibernon Vilaró M; Carrera Plans M; Grinyó Boira JM
Nefrologia; 2008; 28(1):93-8. PubMed ID: 18336138
[TBL] [Abstract][Full Text] [Related]
5. Amyloid load and clinical outcome in AA amyloidosis in relation to circulating concentration of serum amyloid A protein.
Gillmore JD; Lovat LB; Persey MR; Pepys MB; Hawkins PN
Lancet; 2001 Jul; 358(9275):24-9. PubMed ID: 11454373
[TBL] [Abstract][Full Text] [Related]
6. Natural history and outcome in systemic AA amyloidosis.
Lachmann HJ; Goodman HJ; Gilbertson JA; Gallimore JR; Sabin CA; Gillmore JD; Hawkins PN
N Engl J Med; 2007 Jun; 356(23):2361-71. PubMed ID: 17554117
[TBL] [Abstract][Full Text] [Related]
7. Secondary, AA, Amyloidosis.
Papa R; Lachmann HJ
Rheum Dis Clin North Am; 2018 Nov; 44(4):585-603. PubMed ID: 30274625
[TBL] [Abstract][Full Text] [Related]
8. [Amyloidosis in rheumatic diseases].
Zdrojewski Z
Ann Acad Med Stetin; 2010; 56 Suppl 1():7-15. PubMed ID: 21365934
[TBL] [Abstract][Full Text] [Related]
9. Renal AA amyloidosis secondary to morbid obesity?
Alsina E; Martin M; Panadés M; Fernández E
Clin Nephrol; 2009 Oct; 72(4):312-4. PubMed ID: 19825338
[TBL] [Abstract][Full Text] [Related]
10. Serum amyloid A renal amyloidosis in a chronic subcutaneous ("skin popping") heroin user.
Cooper C; Bilbao JE; Said S; Alkhateeb H; Bizet J; Elfar A; Davalos O; Meza AT; Hernandez GT
J Nephropathol; 2013 Jul; 2(3):196-200. PubMed ID: 24475449
[TBL] [Abstract][Full Text] [Related]
11. Heparan sulfate dissociates serum amyloid A (SAA) from acute-phase high-density lipoprotein, promoting SAA aggregation.
Noborn F; Ancsin JB; Ubhayasekera W; Kisilevsky R; Li JP
J Biol Chem; 2012 Jul; 287(30):25669-77. PubMed ID: 22654109
[TBL] [Abstract][Full Text] [Related]
12. Renal AA amyloidosis: presentation, diagnosis, and current therapeutic options: a review.
Karam S; Haidous M; Royal V; Leung N
Kidney Int; 2023 Mar; 103(3):473-484. PubMed ID: 36502873
[TBL] [Abstract][Full Text] [Related]
13. Amyloid A amyloidosis with subcutaneous drug abuse.
Mendoza JM; Peev V; Ponce MA; Thomas DB; Nayer A
J Renal Inj Prev; 2014; 3(1):11-6. PubMed ID: 25340157
[TBL] [Abstract][Full Text] [Related]
14. Systemic AA amyloidosis: epidemiology, diagnosis, and management.
Real de Asúa D; Costa R; Galván JM; Filigheddu MT; Trujillo D; Cadiñanos J
Clin Epidemiol; 2014; 6():369-77. PubMed ID: 25378951
[TBL] [Abstract][Full Text] [Related]
15. AA amyloidosis: basic knowledge, unmet needs and future treatments.
Obici L; Merlini G
Swiss Med Wkly; 2012; 142():w13580. PubMed ID: 22653707
[TBL] [Abstract][Full Text] [Related]
16. Deposition, Clearance, and Reinduction of Amyloid A Amyloid in Interleukin 1 Receptor Antagonist Knockout Mice.
Watanabe K; Uchida K; Chambers JK; Ushio N; Nakayama H
Vet Pathol; 2017 Jan; 54(1):99-110. PubMed ID: 27565681
[TBL] [Abstract][Full Text] [Related]
17. Significant association between renal function and area of amyloid deposition in kidney biopsy specimens in both AA amyloidosis associated with rheumatoid arthritis and AL amyloidosis.
Kuroda T; Tanabe N; Hasegawa E; Wakamatsu A; Nozawa Y; Sato H; Nakatsue T; Wada Y; Ito Y; Imai N; Ueno M; Nakano M; Narita I
Amyloid; 2017 Jun; 24(2):123-130. PubMed ID: 28613962
[TBL] [Abstract][Full Text] [Related]
18. Transmission of systemic AA amyloidosis in animals.
Murakami T; Ishiguro N; Higuchi K
Vet Pathol; 2014 Mar; 51(2):363-71. PubMed ID: 24280941
[TBL] [Abstract][Full Text] [Related]
19. [A review for recent advances in AA amyloid research and therapeutic approach to AA amyloidosis complicating rheumatoid arthritis].
Tamura H; Hasegawa K
Nihon Rinsho Meneki Gakkai Kaishi; 2009 Feb; 32(1):35-42. PubMed ID: 19252376
[TBL] [Abstract][Full Text] [Related]
20. Variation of amino acid sequences of serum amyloid a (SAA) and immunohistochemical analysis of amyloid a (AA) in Japanese domestic cats.
Tei M; Uchida K; Chambers JK; Watanabe KI; Tamamoto T; Ohno K; Nakayama H
J Vet Med Sci; 2018 Feb; 80(1):164-172. PubMed ID: 29199213
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
